Spotlight on Safety: How can long-term GH therapy risks be mitigated?

Are you familiar with the known and unknown safety risks in long-term GH therapy? During this session, Peter Clayton (UK) and Charlotte Höybye (Sweden) discuss how to improve long-term safety of pediatric and adult GH replacement.